Diagnostic Value of Blood Oxygen Saturation and C-Reactive Protein (CRP) in Predicting Lung Sequels in COVID-19 Infected Patients Admitted to Hospital: A 12-week Cohort Study
DOI:
https://doi.org/10.31661/gmj.v12i.2695Keywords:
Lung, Respiratory, COVID-19, OxygenAbstract
Background: Evidence of COVID-19 respiratory sequels is restricted and predisposing factors are not well studied more than two years passing pandemic. This study followed COVID-19 patients 12 weeks after discharge from hospital for respiratory sequels. Materials and Methods: This was a prospective study on discharged COVID-19 patients in 2021, in Jahrom, Iran. Exposure was COVID-19 clinical features at hospitalization, including symptoms and physical examination and laboratory findings, and primary endpoint was 12-week lung sequel, being evaluated by a chest CT scan. Demographics and previous medical history were considered covariates. SPO2 and CRP 6-week changes were followed as an early tool for prediction of 12-week lung sequel. Results: Totally, 383 participants (17 had sequels) with mean age of 57.43±18.03 years old (50.13% male) completed 12-week study follow-ups. Ninety-one (23.8%) subjects had an ICU admission history. SPO2% in 6th week was statistically significantly associated with a higher rate of 12-week sequelae (p<0.001). Also, patients having CT scan scores between 40% to 50% (p=0.012) and higher than 50% (p=0.040) had higher chance of experiencing lung sequelae than patients with CT scan score of below 40%, as well as having ICU admission history and lower SPO2% at 6th week of discharge. There was a statistically significant increasing trend of SPO2% (P<0.001) and a statistically significant decreasing trend of CRP levels (P<0.001), overall. SPO2% increase after 6 weeks was lower in participants with lung sequels than fully improved ones (P=0.002) and as well as total 12-week change in SPO2% (P=0.001). CRP changes in none of evaluated periods were different among study groups (P>0.05). Conclusion: Our results were in favor of closely following SPO2 levels after patient discharge, while CRP assessment seems not helpful based on our results.
References
Afsahi A, Lombardi A, Valizadeh S, Gholamrezanezhad A, Behera B, Azhar A, et al. WJCID. World. 2021;11(1):1-34. https://doi.org/10.5495/wjcid.v11.i1.1 Park WB, Jun KI, Kim G, Choi J-P, Rhee J-Y, Cheon S, et al. Correlation between pneumonia severity and pulmonary complications in Middle East respiratory syndrome. J Korea Med Sci. 2018;33(24). https://doi.org/10.3346/jkms.2018.33.e169PMid:29892209 PMCid:PMC5990444 Cao J, Zheng X, Wei W, Chu X, Chen X, Wang Y, et al. Three-month outcomes of recovered COVID-19 patients: prospective observational study. Therap Advn Resp Dis. 2021;15:17534666211009410. https://doi.org/10.1177/17534666211009410PMid:33878961 PMCid:PMC8064514 Zou J-N, Sun L, Wang B-R, Zou Y, Xu S, Ding Y-J, et al. The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT. PloS one. 2021;16(3):e0248957. https://doi.org/10.1371/journal.pone.0248957PMid:33755708 PMCid:PMC7987145 Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397(10270):220-32. https://doi.org/10.1016/S0140-6736(20)32656-8PMid:33428867 Huntley CC, Patel K, Mobeen F, Armitage MN, Pye A, Knight CB, et al. Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysis. ERJ Opn Res. 2022;8(2). https://doi.org/10.1183/23120541.00056-2022PMid:35642193 PMCid:PMC9035766 Salem AM, Al Khathlan N, Alharbi AF, Alghamdi T, AlDuilej S, Alghamdi M, et al. The long-term impact of COVID-19 pneumonia on the pulmonary function of survivors. Int J Genr Med. 2021;14:3271. https://doi.org/10.2147/IJGM.S319436PMid:34267545 PMCid:PMC8276825 Musat C, Hadzhiivanov M, Durkowski V, Banerjee A, Chiphang A, Diwan M, et al. Observational study of clinico-radiological follow-up of COVID-19 pneumonia: a district general hospital experience in the UK. BMC Infc Dis. 2021;21(1):1-8. https://doi.org/10.1186/s12879-021-06941-8PMid:34879817 PMCid:PMC8651500 Rosner B. Fundamentals of Biostatistics (The 7th edition). Boston, MA: Brooks/Cole. 2011. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiol. 2020;295(3):715-21. https://doi.org/10.1148/radiol.2020200370PMid:32053470 PMCid:PMC7233367 Shah AS, Wong AW, Hague CJ, Murphy DT, Johnston JC, Ryerson CJ, et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76(4):402-4. https://doi.org/10.1136/thoraxjnl-2020-216308PMid:33273023 PMCid:PMC7716339 Sahraeai R, Sarikhani Y, Kalani N, Hatami N, Abiri AA, Eftekharian F. Prevalence of Gastrointestinal Symptoms in Patients with COVID-19 in Jahrom County, Fras Province, Southwest of Iran. J Med Chem Sci. 2022;5(4):483-90. Sanie Jahromi MS, Aghaei K, Taheri L, Kalani N, Hatami N, Rahmanian Z. Intensive Care Unit of COVID-19 during the Different Waves of Outbreaks in Jahrom, South of Iran. J Med Chem Sci. 2022;5(5):734-42. Lu X, Jiang L, Chen T, Wang Y, Zhang B, Hong Y, et al. Continuously available ratio of SpO 2/FiO 2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Resp Res. 2020;21(1):1-4. https://doi.org/10.1186/s12931-020-01455-4PMid:32698822 PMCid:PMC7374662 George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75(11):1009-16. https://doi.org/10.1136/thoraxjnl-2020-215314PMid:32839287 PMCid:PMC7447111 Mueller AA, Tamura T, Crowley CP, DeGrado JR, Haider H, Jezmir JL, et al. Inflammatory biomarker trends predict respiratory decline in COVID-19 patients. Cel Rep Med. 2020;1(8):100144. https://doi.org/10.1016/j.xcrm.2020.100144PMid:33163981 PMCid:PMC7598305 Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396-8. https://doi.org/10.1136/thoraxjnl-2020-215818PMid:33172844 PMCid:PMC7661378 Saab FG, Chiang JN, Brook R, Adamson PC, Fulcher JA, Halperin E, et al. Discharge clinical characteristics and post-discharge events in patients with severe COVID-19: a descriptive case series. J Genr Inter Med. 2021;36(4):1017-22. https://doi.org/10.1007/s11606-020-06494-7PMid:33532963 PMCid:PMC7853705 Abdullah F, Myers J, Basu D, Tintinger G, Ueckermann V, Mathebula M, et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa. Int J Inf Dis. 2022;116:38-42. https://doi.org/10.1016/j.ijid.2021.12.357PMid:34971823 PMCid:PMC8713416 Christensen PA, Olsen RJ, Long SW, Snehal R, Davis JJ, Saavedra MO, et al. Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with Coronavirus disease 2019 caused by the Omicron variant of severe acute respiratory syndrome Coronavirus 2 in Houston, Texas. The Amerc J Patol. 2022;192(4):642-52. https://doi.org/10.1016/j.ajpath.2022.01.007PMid:35123975 PMCid:PMC8812084 Mogharab V, Ostovar M, Ruszkowski J, Hussain SZM, Shrestha R, Yaqoob U, et al. Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses. Glob Helt. 2022;18(1):1-18. https://doi.org/10.1186/s12992-022-00836-2PMid:35676714 PMCid:PMC9175527
